IMMUNOHISTOCHEMICAL ANALYSIS OF P53 IN GYNECOLOGIC TUMORS

被引:65
作者
INOUE, M [1 ]
FUJITA, M [1 ]
ENOMOTO, T [1 ]
MORIMOTO, H [1 ]
MONDEN, T [1 ]
SHIMANO, T [1 ]
TANIZAWA, O [1 ]
机构
[1] OSAKA UNIV, SCH MED, DEPT SURG 2, OSAKA 553, JAPAN
关键词
FEMALE GENITAL NEOPLASMS; IMMUNOHISTOCHEMISTRY; ONCOGENES; OVARIAN CARCINOMA; P53; UTERINE CARCINOMA;
D O I
10.1093/ajcp/102.5.665
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Immunohistochemical staining for the p53 protein was performed in microwave-fixed, paraffin-embedded sections of normal, premalignant and malignant tissues of the female genital tract using a monoclonal antibody, PAb 1801. No staining was detected in normal and premalignant tissues, whereas nuclear staining of cancer cells was observed in 12 (22%) of 55 cervical squamous cell carcinomas, 4 (25%) of 16 cervical adenocarcinomas, 37 (42%) of 88 endometrial carcinomas, 23 (38%) of 60 ovarian adenocarcinomas, and 6 (100%) of 6 squamous cell carcinomas arising in dermoid cysts. Of interest, 1 of 7 endometrial cancers with concomitant atypical hyperplasia showed weak nuclear staining in a few atypical hyperplastic glands in addition to the cancerous lesions. Although staining was associated with cancers having a high histologic grade and serous papillary adenocarcinomas of the endometrium, it did not correlate with invasion, metastasis, or clinical stage. Comparison of the staining patterns with molecular analysis of mutations in the p53 gene showed the expected correlation of nuclear staining with missense mutations but not with nonsense mutations, which consistuted one third of all mutations found in this series. In addition, cytoplasmic staining did not predict mutation.
引用
收藏
页码:665 / 670
页数:6
相关论文
共 37 条
[1]  
AZUMI N, 1990, MODERN PATHOL, V3, P368
[2]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[3]   ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION [J].
BANKS, L ;
MATLASHEWSKI, G ;
CRAWFORD, L .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03) :529-534
[4]   PATTERNS OF EXPRESSION OF THE P53 TUMOR SUPPRESSOR IN HUMAN BREAST TISSUES AND TUMORS INSITU AND INVITRO [J].
BARTEK, J ;
BARTKOVA, J ;
VOJTESEK, B ;
STASKOVA, Z ;
REJTHAR, A ;
KOVARIK, J ;
LANE, DP .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (05) :839-844
[5]   P53 PROTEIN ALTERATIONS IN HUMAN TESTICULAR CANCER INCLUDING PREINVASIVE INTRATUBULAR GERM-CELL NEOPLASIA [J].
BARTKOVA, J ;
BARTEK, J ;
LUKAS, J ;
VOJTESEK, B ;
STASKOVA, Z ;
REJTHAR, A ;
KOVARIK, J ;
MIDGLEY, CA ;
LANE, DP .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (02) :196-202
[6]   P53 EXPRESSION IN BREAST-CANCER [J].
CATTORETTI, G ;
RILKE, F ;
ANDREOLA, S ;
DAMATO, L ;
DELIA, D .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) :178-183
[7]   MONOCLONAL-ANTIBODIES AGAINST RECOMBINANT PARTS OF THE KI-67 ANTIGEN (MIB-1 AND MIB-3) DETECT PROLIFERATING CELLS IN MICROWAVE-PROCESSED FORMALIN-FIXED PARAFFIN SECTIONS [J].
CATTORETTI, G ;
BECKER, MHG ;
KEY, G ;
DUCHROW, M ;
SCHLUTER, C ;
GALLE, J ;
GERDES, J .
JOURNAL OF PATHOLOGY, 1992, 168 (04) :357-363
[8]  
CLEMENT PB, 1993, TUMORS TUMORLIKE LES, P181
[9]  
COLTRERA MD, 1991, LAB INVEST, V64, pA63
[10]  
CROOK T, 1991, ONCOGENE, V6, P873